BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 1600018)

  • 1. Pancoast's syndrome due to pulmonary infection with Cryptococcus neoformans variety gattii.
    Mitchell DH; Sorrell TC
    Clin Infect Dis; 1992 May; 14(5):1142-4. PubMed ID: 1600018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cryptococcus neoformans vertebral osteomyelitis.
    Gurevitz O; Goldschmied-Reuven A; Block C; Kopolovic J; Farfel Z; Hassin D
    J Med Vet Mycol; 1994; 32(4):315-8. PubMed ID: 7983576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Voriconazole, combined with amphotericin B, in the treatment for pulmonary cryptococcosis caused by C. neoformans (serotype A) in mice with severe combined immunodeficiency (SCID).
    Silva EG; Paula CR; de Assis Baroni F; Gambale W
    Mycopathologia; 2012 Jun; 173(5-6):445-9. PubMed ID: 22071662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pulmonary cryptococcosis treated by combination therapy of fluconazole plus flucytosine].
    Tanaka K; Kohno S; Maesaki S; Mitsutake K; Miyazaki H; Miyazaki T; Tomono K; Kaku M; Koga H; Hara K
    Nihon Kyobu Shikkan Gakkai Zasshi; 1993 Dec; 31(12):1528-33. PubMed ID: 8121088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of amphotericin B in combination with flucytosine against flucytosine-susceptible or flucytosine-resistant isolates of Cryptococcus neoformans during disseminated murine cryptococcosis.
    Schwarz P; Dromer F; Lortholary O; Dannaoui E
    Antimicrob Agents Chemother; 2006 Jan; 50(1):113-20. PubMed ID: 16377675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coexistent pulmonary cryptococcal infection and pulmonary sarcoidosis: a case report and literature review.
    Zhou B; She J; Yang L; Zhu B
    J Int Med Res; 2020 Feb; 48(2):300060520903870. PubMed ID: 32070156
    [No Abstract]   [Full Text] [Related]  

  • 7. [Cryptococcosis].
    Yoshida K; Shoji H; Niki Y
    Nihon Rinsho; 2008 Dec; 66(12):2350-5. PubMed ID: 19069104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful treatment with voriconazole combined with amphotericin B-liposome for fluconazole-resistant pulmonary cryptococcosis after renal transplantation.
    Fujioka K; Nagai T; Kinoshita Y; Urushihara M; Hamasaki Y; Shishido S; Kagami S
    CEN Case Rep; 2019 Nov; 8(4):261-265. PubMed ID: 31161376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mycological-diagnostic assessment of the efficacy of amphotericin B + flucytosine to control Cryptococcus neoformans in AIDS patients.
    Staib F; Seibold M
    Mycoses; 1988 Apr; 31(4):175-86. PubMed ID: 3405247
    [No Abstract]   [Full Text] [Related]  

  • 10. Fluconazole-resistant Cryptococcus neoformans isolated from an immunocompetent patient without prior exposure to fluconazole.
    Orni-Wasserlauf R; Izkhakov E; Siegman-Igra Y; Bash E; Polacheck I; Giladi M
    Clin Infect Dis; 1999 Dec; 29(6):1592-3. PubMed ID: 10585832
    [No Abstract]   [Full Text] [Related]  

  • 11. Current approach to the acute management of cryptococcal infections.
    Powderly WG
    J Infect; 2000 Jul; 41(1):18-22. PubMed ID: 11041709
    [No Abstract]   [Full Text] [Related]  

  • 12. Early onset primary pulmonary cryptococcosis in a renal transplant patient.
    Tarai B; Kher V; Kotru P; Sabhikhi A; Barman P; Rattan A
    Indian J Med Microbiol; 2010; 28(3):250-2. PubMed ID: 20644317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulmonary cryptococcosis in the immunocompetent host. Therapy with oral fluconazole: a report of four cases and a review of the literature.
    Núñez M; Peacock JE; Chin R
    Chest; 2000 Aug; 118(2):527-34. PubMed ID: 10936151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro and in vivo antifungal activities of T-2307, a novel arylamidine, against Cryptococcus gattii: an emerging fungal pathogen.
    Nishikawa H; Fukuda Y; Mitsuyama J; Tashiro M; Tanaka A; Takazono T; Saijo T; Yamamoto K; Nakamura S; Imamura Y; Miyazaki T; Kakeya H; Yamamoto Y; Yanagihara K; Mukae H; Kohno S; Izumikawa K
    J Antimicrob Chemother; 2017 Jun; 72(6):1709-1713. PubMed ID: 28201509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proven pulmonary cryptococcosis due to capsule-deficient Cryptococcus neoformans does not differ clinically from proven pulmonary cryptococcosis due to capsule-intact Cr. neoformans.
    Torres HA; Prieto VG; Raad II; Kontoyiannis DP
    Mycoses; 2005 Jan; 48(1):21-4. PubMed ID: 15679661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A case of pulmonary cryptococcosis followed by pleuritis in an apparently immunocompetent patient during fluconazole treatment.
    Izumikawa K; Zhao Y; Motoshima K; Takazono T; Saijo T; Kurihara S; Nakamura S; Miyazaki T; Seki M; Kakeya H; Yamamoto Y; Yanagihara K; Miyazaki Y; Hayashi T; Kohno S
    Med Mycol; 2008 Sep; 46(6):595-9. PubMed ID: 19180728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disseminated Cryptococcus neoformans: case report and review of the literature.
    Patel NC; Ewanowski C; Kupiec-Banasikowska A; Hogan KP
    Cutis; 2009 Aug; 84(2):93-6. PubMed ID: 19746767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In-vitro and in-vivo activities of SCH56592 against Cryptococcus neoformans.
    Hossain MA; Maesaki S; Mitsutake K; Kakeya H; Sasaki E; Tomono K; Tashiro T; Kohno S
    J Antimicrob Chemother; 1999 Dec; 44(6):827-9. PubMed ID: 10590286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cryptococcosis complicating continuous ambulatory peritoneal dialysis.
    Kaczmarski EB; Tooth JA; Anastassiades E; Manos J; Gokal R
    J Infect; 1989 May; 18(3):289-92. PubMed ID: 2664000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and host differences between infections with the two varieties of Cryptococcus neoformans.
    Speed B; Dunt D
    Clin Infect Dis; 1995 Jul; 21(1):28-34; discussion 35-6. PubMed ID: 7578756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.